Therapeutic potential of glycosaminoglycan-peptide complex injectable form use in knee osteoarthritis treatment according to PRIMULA (Use of Rumalon with initially small success in the treatment of osteoarthritis) study results: supplemented data
- Authors: Karateev A.E1, Alekseeva L.I1, Lila A.M1, Makarov S.A1, Chichasova N.V2, Zonova E.V3, Shmidt E.I4, Taskina E.A1, Kashevarova N.G1, Sharapova E.P1, Anikin S.G1, Strebkova E.A1, Azarovskaya V.V4
-
Affiliations:
- V.A.Nasonova Research Institute of Rheumatology
- I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- Novosibirsk State Medical University of the Ministry of Health of the Russian Federation
- N.I.Pirogov City Сlinical Hospital №1 of the Department of Health of Moscow
- Issue: Vol 20, No 9 (2018)
- Pages: 51-57
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95086
- DOI: https://doi.org/10.26442/2075-1753_2018.9.51-57
- ID: 95086
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. E Karateev
V.A.Nasonova Research Institute of Rheumatology
Email: aekarat@yandex.ru
д-р мед. наук, зав. лаб. патофизиологии боли и полиморфизма скелетно-мышечных заболеваний 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
L. I Alekseeva
V.A.Nasonova Research Institute of Rheumatology
Email: dr.alekseeva@gmail.com
д-р мед. наук, зав. лаб. остеоартроза с отд. метаболических заболеваний костей и суставов с центром профилактики остеопороза 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
A. M Lila
V.A.Nasonova Research Institute of Rheumatologyд-р мед. наук, проф., дир. 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
S. A Makarov
V.A.Nasonova Research Institute of Rheumatologyканд. мед. наук, зав. отд-нием травматологии и ортопедии, врач травматолог-ортопед 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
N. V Chichasova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federationд-р мед. наук, проф. каф. ревматологии 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
E. V Zonova
Novosibirsk State Medical University of the Ministry of Health of the Russian Federation
Email: elena_zonova@list.ru
д-р мед. наук, проф. каф. терапии, гематологии и трансфузиологии ФПК и ППВ , гл. специалист-ревматолог СФО. 630091, Russian Federation, Novosibirsk, ul. Krasnyi pr-t, d. 52
E. I Shmidt
N.I.Pirogov City Сlinical Hospital №1 of the Department of Health of Moscow119049, Russian Federation, Moscow, Leninskii pr-t, d. 10, korp. 5
E. A Taskina
V.A.Nasonova Research Institute of Rheumatology
Email: braell@mail.ru
канд. мед. наук, науч. сотр. лаб. остеоартроза с отд. метаболических заболеваний костей и суставов с центром профилактики остеопороза 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
N. G Kashevarova
V.A.Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
канд. мед. наук, науч. сотр. лаб. остеоартроза с отд. метаболических заболеваний костей и суставов с центром профилактики остеопороза 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
E. P Sharapova
V.A.Nasonova Research Institute of Rheumatology
Email: 2116i@mail.ru
канд. мед. наук, науч. сотр. лаб. остеоартроза с отд. метаболических заболеваний костей и суставов с центром профилактики остеопороза 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
S. G Anikin
V.A.Nasonova Research Institute of Rheumatologyканд. мед. наук, ст. науч. сотр. лаб. остеоартроза, отд. метаболических заболеваний костей и суставов с центром профилактики остеопороза 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
E. A Strebkova
V.A.Nasonova Research Institute of Rheumatology
Email: ekaterinazlepko@gmail.com
канд. мед. наук, науч. сотр. лаб. остеоартроза с отд. метаболических заболеваний костей и суставов с центром профилактики остеопороза 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34a
V. V Azarovskaya
N.I.Pirogov City Сlinical Hospital №1 of the Department of Health of Moscow
Email: aekarat@yandex.ru
ревматолог 119049, Russian Federation, Moscow, Leninskii pr-t, d. 10, korp. 5
References
- Laires P.A, Canhão H, Rodrigues A.M et al. The impact of osteoarthritis on early exit from work: results from a population-based study. BMC Public Health 2018; 18 (1): 472. doi: 10.1186/s12889-018-5381-1
- Murphy N.J, Eyles J.P, Hunter D.J. Hip Osteoarthritis: Etiopathogenesis and Implications for Management. Adv Ther 2016; 33 (11): 1921-46.
- Xie F, Kovic B, Jin X et al. Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies. Pharmacoeconomics 2016; 34 (11): 1087-100.
- Балабанова Р.М., Дубинина Т.В., Демина А.Б., Кричевская О.А. Заболеваемость болезнями костно-мышечной системы в Российской Федерации за 2015-2016 гг. Научно-практическая ревматология. 2018; 56 (1): 15-21. doi: 10.14412/1995-4484-2018-15-21
- Фоломеева O.M., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяциях взрослого населения России и США. Научно-практическая ревматология. 2008; 46 (4): 4-13.
- Кашеварова Н.Г., Алексеева Л.И., Таскина Е.А., Смирнов А.В. Ведущие факторы прогрессирования остеоартрита коленных суставов. Влияние симптоматических препаратов замедленного действия на течение заболевания (5-летнее проспективное исследование). Фарматека. 2017; 7 (340): 40-6
- Алексеева Л.И. Новые подходы к ведению больных остеоартрозом в реальной клинической практике. Практическая медицина. 2015; 3-2 (88): 77-83.
- Bruyère O, Cooper C, Pelletier J.P et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum 2016; 45 (4 Suppl.): S3-11. doi: 10.1016/j.semarthrit.2015.11.010
- Klein R, Becker E.W, Berg P.A, Bernau A. Immunomodulatory properties of rumalon, a glycosaminoglycan peptide complex, in patients with osteoarthritis: activation of T helper cell type 2 cytokines and antigen-specific IgG4 antigen-specific igG4 antibodies. J Rheumatol 2000; 27 (2): 448-54.
- Dean D, Muniz O, Rodriquez I et al. Amelioration of lapine osteo- arthritis by treatment with glycosaminoglycan-peptide association complex (Rumalon). Arthritis Rheum 1991; 34: 304-13.
- Vignon E, Martin A, Mathieu P et al. Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage. Clin Rheumatol 1990; 9 (3): 383-8.
- Bouakka M, Loyau G, Bocquet J. Effect of a glycosaminoglycan-peptide complex on the biosynthesis of protoglycans in articular chondrocytes treated with interleukin-1. Curr Ther Res 1988; 43: 588-99.
- Annefeld M, Erne B. The mode of action of a glycosaminoglycan-peptide-complex (Rumalon) on articular cartilage of the rat in vivo. Clin Rheumatol 1987; 6 (3): 340-9.
- Насонова В.А. Диагностика и лечение больных пожилого возраста, страдающих манифестным остеоартрозом. РМЖ. 2001; 3: 157-62.
- Altman R.D. Measurement of structure (disease) modification in osteoarthritis. Osteoarthritis Cartilage 2004; (12 Suppl. A): S69-76.
- Calders P, Van Ginckel A. Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2017. pii: S0049-0172(17)30564-4. doi: 10.1016/j.semarthrit.2017.10.016. [Epub ahead of print]
- Duffield S.J, Ellis B.M, Goodson N et al. The contribution of musculoskeletal disorders in multimorbidity: Implications for practice and policy. Best Pract Res Clin Rheumatol 2017; 31 (2): 129-44. doi: 10.1016/j.berh.2017.09.004
- Rejholec V, Králová M. [Long-term treatment of coxarthrosis using Rumalon. Comparative study on 224 patients, observation period of 8 years]. [Article in German]. Z Rheumatol 1974; 33 (11-12): 425-36.
- Rejholec V, Králová M. Langzeitbehandlung der Coxarthrose mit Rumalon® Akt Rheumatol 1984; 9: 139-48 doi: 10.1055/s-2008-1048133
- Adler E, Wolf E, Taustein I. A double blind trial with cartilage and bone marrow extract in degenerative gonarthrosis. Scand J Rheumatol 1987; 16 (1): 6-11. doi: 10.3109/03009747009165349.
- Gramajo R.J , Cutroneo E.J, Fernandez D.E et al. A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or knee. Curr Med Res Opin 1989; 11 (6): 366-73.
- Katona G. A clinical trial of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the knee. Curr Med Res Opin 1987; 10 (9): 625-33.
- Алексеева Л.И., Карякин А.Н., Смирнов А.В., Беневоленская Л.И. Применение Румалона при гонартрозе. Терапевтический архив. 1997; 5: 64-6.
- Mills K, Hübscher M, O'Leary H, Moloney N. Current concepts in joint pain in knee osteoarthritis. Schmerz 2018. doi: 10.1007/s00482-018-0275-9. [Epub ahead of print]
- Mathiessen A, Conaghan P.G. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res Ther 2017; 19 (1): 18. doi: 10.1186/s13075-017-1229-9
- Scanzello C.R, Goldring S.R. The role of synovitis in osteoarthritis pathogenesis. Bone 2012; 51 (2): 249-57. doi: 10.1016/j.bone.2012.02.012
- Slobodin G, Rimar D, Boulman N et al. Entheseal involvement in systemic disorders. Clin Rheumatol 2015; 34 (12): 2001-10. doi: 10.1007/s10067-015-3068-x
- McGonagle D, Hermann K.G, Tan A.L. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford) 2015; 54 (1): 29-38. doi: 10.1093/rheumatology/keu328
- McGonagle D, Aydin S.Z, Tan A.L. The synovio-entheseal complex and its role in tendon and capsular associated inflammation. J Rheumatol Suppl 2012; 89: 11-4. doi: 10.3899/jrheum.120233
- Benjamin M, McGonagle D. Histopathologic changes at "synovio-entheseal complexes" suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis. Arthritis Rheum. 2007; 56 (11): 3601-9.